Twenty-five years of acid secretion inhibitors;25 jaar maagzuursecretieremmende medicamenten

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 50, 1999, Pages 2501-2504

  Lamers, C B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

DRUG EFFECT; DRUG SAFETY; DYSPEPSIA; GASTRODUODENAL ULCER; GASTROESOPHAGEAL REFLUX; HUMAN; PEPTIC ULCER; REFLUX ESOPHAGITIS; RESEARCH; REVIEW; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

ANTI-ULCER AGENTS; CIMETIDINE; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; NETHERLANDS; OMEPRAZOLE; PEPTIC ULCER; STOMACH ULCER; ZOLLINGER-ELLISON SYNDROME;

EID: 0033547660     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. 2-receptorantagonists in Zollinger-Ellison syndrome. Am J Gastroenterol 1978;70:286-91.
2. Lamers CBHW, Jansen JBMJ. Inhibition of gastric acid secretion in Zollinger-Ellison syndrome by omeprazole, a potent and long-acting antisecretory drug [abstract]. Gut 1982;23:A907.
3. Lamers CBHW, Lind T, Moberg S, Jansen JBMJ, Olbe L. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. N Engl J Med 1984;310:758-61.
4. Milton-Thompson GJ, Williams JG, Jenkins DJA, Misiewicz JJ. Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide. Lancet 1974;i:693-4.
5. Festen HPM, Lamers CBHW, Tongeren JHM van. Cimetidine in clinical use. A review. Neth J Med 1980;23:210-7.
6. Wesdorp E, Bartelsman J, Pape K, Dekker W, Tytgat GN. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978;74(5 Pt 1):821-4.
7. Klinkenberg-Knol EC, Jansen JM, Festen HPM, Meuwissen SGM, Lamers CBHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987;i:349-51.
8. Klinkenberg-Knol EC, Festen HP, Jansen JBMJ, Lamers CBHW, Nelis F, Snel P, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161-7.
9. Jansen JBMJ, Klinkenberg-Knol EC, Meuwissen SGM. Bruijne JW de, Festen HPM, Snel P, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990;99: 621-8.
10. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena E, Nelis GF, Festen HPM, et al. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:605-12.
11. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
12. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Bloemena E, Meuwissen SGM. Incidence and risk factors of gastric polyp formation during long-term omeprazole therapy for gastroesophageal reflux disease. In: Schenk BE. Studies on Helicobacter pylori and long-term profound acid suppression [proefschrift]. Amsterdam: Vrije Universiteit; 1999. p. 113-26.
13. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SGM. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999;94:884-7.
14. Bruyne JW de, Lamers CBHW, Dekkers CPM. Omeprazole induces faster healing and pain relief than cimetidine in duodenal ulcer patients. J Clin Nutr Gastroenterol 1993;8:1-6.
15. Walan A, Bader JP, Classer, M, Lamers CBHW, Piper DW, Rutgersson K, et al. Effect of omprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
16. Tytgat GNJ, Lamers CBHW, Hameeteman W, Jansen JM, Wilson JA. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Ther 1987;1:31-8.
17. Schaffalitzky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM, et al. Effect of Omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997;32:320-7.
18. Heijerman HG, Lamers CBHW, Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 1991;114:200-1.